A detailed history of Elite Wealth Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Elite Wealth Management, Inc. holds 463 shares of LLY stock, worth $346,328. This represents 0.1% of its overall portfolio holdings.

Number of Shares
463
Previous 443 4.51%
Holding current value
$346,328
Previous $401,000 2.24%
% of portfolio
0.1%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $15,442 - $19,200
20 Added 4.51%
463 $410,000
Q2 2024

Aug 12, 2024

SELL
$724.87 - $909.04 $4,349 - $5,454
-6 Reduced 1.34%
443 $401,000
Q1 2024

Apr 24, 2024

BUY
$592.2 - $792.28 $265,897 - $355,733
449 New
449 $349,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Elite Wealth Management, Inc. Portfolio

Follow Elite Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elite Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Elite Wealth Management, Inc. with notifications on news.